FDA Orders Post-Market Studies On Metal-On-Metal Hips
This article was originally published in The Gray Sheet
Executive Summary
FDA has ordered 21 current and former manufacturers of metal-on-metal total hip replacement systems to conduct post-market surveillance studies of their devices to assess metal toxicity risks.